Frequency of Disease Flares Under Long-Term Anti-TNF Therapy in Patients with Early Axial Spondyloarthritis: Results from the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis Trial (ESTHER)

Proft, Fabian; Torgutalp, Murat; Weiss, Anja; Protopopov, Mikhail; Rodriguez, Valeria Rios; Haibel, Hildrun; Hermann, Kay-Geert; Althoff, Christian; Behmer, Olaf; Sieper, Joachim; Poddubnyy, Denis

doi:10.81043/aperta.71687

Dergi makalesi Açık Erişim

Frequency of Disease Flares Under Long-Term Anti-TNF Therapy in Patients with Early Axial Spondyloarthritis: Results from the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis Trial (ESTHER)

2019 Proft, Fabian; Torgutalp, Murat; Weiss, Anja; Protopopov, Mikhail; Rodriguez, Valeria Rios; Haibel, Hildrun; Hermann, Kay-Geert; Althoff, Christian; Behmer, Olaf; Sieper, Joachim; Poddubnyy, Denis

Öz bulunamadı.

Dosyalar (395 Bytes)

Dosya adı	Boyutu
bib-a1c99c77-4c7c-41f8-88b3-a1ae327b131c.txt md5:0b4765ffecb33d47dc517955c76afe59	395 Bytes	İndir

görüntülenme

indirilme

Daha fazla ayrıntı...

Görüntülenme	29
İndirme	7
Veri hacmi	2.8 kB
Tekil görüntülenme	28
Tekil indirme	7

Kayıt Bilgileri

Yayınlanma tarihi:: 01/01/2019
Yayınlandığı yer:: ARTHRITIS & RHEUMATOLOGY: 71.
Lisans:: Creative Commons Attribution

Frequency of Disease Flares Under Long-Term Anti-TNF Therapy in Patients with Early Axial Spondyloarthritis: Results from the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis Trial (ESTHER)

Frequency of Disease Flares Under Long-Term Anti-TNF Therapy in Patients with Early Axial Spondyloarthritis: Results from the Etanercept versus Sulfasalazine in Early Axial Spondyloarthritis Trial (ESTHER)

Kayıt Bilgileri

Alıntı yap

Paylaş

Dışa aktar

TÜBİTAK ULAKBİM

İLETİŞİM